Press Releases

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 26, 2019-- TransEnterix, Inc. (NYSE American: TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Feb. 12, 2019-- TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release fourth quarter and fiscal year 2018 financial and operating results before the market opens on Tuesday, February 26, 2019 . Todd M.

Senhance Ultrasonic advanced energy capability broadens potential applicability of Senhance surgery in the United States RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Jan. 15, 2019-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between

Sold five Senhance™ Systems globally in fourth quarter of 2018 Achieved preliminary unaudited revenue of approximately $7.4 million for the fourth quarter of 2018 Received Taiwanese FDA approval for the Senhance System instruments in fourth quarter of 2018 Launched Ultrasonic Instrument System in

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Dec. 20, 2018-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope , President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the 37th Annual J.P.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Nov. 15, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, today announced its naming to Deloitte’s 2018 Technology Fast 500

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Nov. 8, 2018-- TransEnterix, Inc. (NYSE American:TRXC), a medical device company that is digitizing the interface between the surgeon and the patient to improve minimally invasive surgery, today announced its operating and financial results for the

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 31, 2018-- TransEnterix, Inc. (NYSE American:TRXC) announced today that Todd M. Pope, President and Chief Executive Officer, and Joseph P. Slattery , Executive Vice President and Chief Financial Officer, will present at the Stifel 2018 Healthcare

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 24, 2018-- TransEnterix, Inc. (NYSE American: TRXC) announced today that it plans to release third quarter 2018 financial and operating results after the market closes on Thursday, November 8, 2018 . Todd M.

RESEARCH TRIANGLE PARK, N.C. --(BUSINESS WIRE)--Oct. 18, 2018-- TransEnterix, Inc.  (NYSE American:TRXC), a medical device company that is digitizing the interface between surgeons and patients to improve minimally invasive surgery, congratulates its President and Chief Executive Officer, Todd M.